Attila Nakeeb to Antineoplastic Combined Chemotherapy Protocols
This is a "connection" page, showing publications Attila Nakeeb has written about Antineoplastic Combined Chemotherapy Protocols.
Connection Strength
0.094
-
Kim RC, Allen KA, Roch AM, McGuire SP, Ceppa EP, Zyromski NJ, Nakeeb A, House MG, Schmidt CM, Nguyen TK. Neoadjuvant therapy at local versus outside institutions does not adversely impact surgical timing or long-term outcomes in patients with pancreatic adenocarcinoma. Surgery. 2023 03; 173(3):574-580.
Score: 0.038
-
Flick KF, Al-Temimi MH, Maatman TK, Sublette CM, Swensson JK, Nakeeb A, Ceppa EP, Nguyen TK, Schmidt CM, Zyromski NJ, Tann MA, House MG. Hepatic Steatosis After Neoadjuvant Chemotherapy for Pancreatic Cancer: Incidence and Implications for Outcomes After Pancreatoduodenectomy. J Gastrointest Surg. 2020 09; 24(9):2008-2014.
Score: 0.032
-
Simianu VV, Zyromski NJ, Nakeeb A, Lillemoe KD. Pancreatic cancer: progress made. Acta Oncol. 2010 May; 49(4):407-17.
Score: 0.016
-
Koniaris LG, Lillemoe KD, Yeo CJ, Abrams RA, Colemann J, Nakeeb A, Pitt H, Cameron JL. Is there a role for surgical resection in the treatment of early-stage pancreatic lymphoma? J Am Coll Surg. 2000 Mar; 190(3):319-30.
Score: 0.008